<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00586027</url>
  </required_header>
  <id_info>
    <org_study_id>CI/NT-proBNP-12-2007</org_study_id>
    <nct_id>NCT00586027</nct_id>
  </id_info>
  <brief_title>Is There a Correlation of Natriuretic Propeptide Type B With an Intraoperative Low Cardiac Output?</brief_title>
  <official_title>Prospective Observational Study in Patients Undergoing Cardiac Surgery: Part 2: Is There a Correlation of Natriuretic Propeptide Type B With an Intraoperative Low Cardiac Output?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Klinikum Ludwigshafen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Klinikum Ludwigshafen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Low output syndrome is a common complication in patients undergoing cardiac surgery. Its
      incidence was reported to be 2 to 6%. Morbidity and mortality of low output syndrome is high
      and the costs for treating the disease are immense.Natriuretic propeptide Type B (NT-proBNP)
      is a biological marker for the diagnosis, prognosis and therapy of cardiac failure after
      cardiac surgery.

      Cardiac index and NT-proBNP will be correlated with morbidity and mortality. A critical
      threshold value for intraoperative cardiac index and NT-proBNP will be calculated.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Low output syndrome is a common complication in patients undergoing cardiac surgery. Its
      incidence was reported to be 2 to 6% [1]. In patients suffering from low output syndrome
      cardiac output is severely reduced due to myocardial failure. Among other reasons for
      myocardial failure, ischemia, insufficient myocardial protection during aortic
      cross-clamping, and severely reduced ventricular function prior surgery are the most common
      risk factors for low output syndrome. Low output syndrome is treated with positive inotropic
      drugs and mechanical assist devices [2]. Morbidity and mortality of low output syndrome is
      high and the costs for treating the disease are immense.

      If cardiac output cannot be increased cardiac failure persist and vital organs are
      hypoperfused. Critical and prolonged hypoperfusion results in single and multi organ failure.
      Until today a definite threshold for a critically reduced cardiac output or cardiac index
      requiring immediate therapy is not completely known. Cardiogenic shock is diagnosed by
      clinical signs and it is not diagnosed by cardiac output or cardiac index. The critical value
      for a severely reduces cardiac index was reported to be in a range of 1.75 to 2.5L/min/m²
      [3-5].

      Natriuretic propeptide Type B (NT-proBNP) is a biological marker for the diagnosis, prognosis
      and therapy of cardiac failure after cardiac surgery [6,7].

      The primary objective of this prospective observational study in 150 patients undergoing
      cardiac surgery with an intraoperative measured cardiac output &lt;2L/min/m² is to monitor
      NT-proBNP for 7 days. Cardiac index and NT-proBNP will be correlated with morbidity and
      mortality [8]. A critical threshold value for intraoperative cardiac index and NT-proBNP will
      be calculated.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The primary objective is to monitor NT-proBNP for 7 days in patients with an intraoperative low cardiac output. Cardiac index and NT-proBNP will be correlated with morbidity and mortality.</measure>
    <time_frame>90 days</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Cardiac Surgery</condition>
  <condition>Low Cardiac Output</condition>
  <condition>Natriuretic Peptide B</condition>
  <arm_group>
    <arm_group_label>NT-proBNP</arm_group_label>
    <description>150 consecutive patients undergoing cardiac surgery with an intraoperative measured cardiac output &lt;2L/min/m².</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        150 patients undergoing cardiac surgery, being monitored with a Swan-Ganz catheter and an
        intraoperatively before cardiopulmonary bypass measured cardiac index &lt;2L/min/m².
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patient undergoing cardiac surgery

          -  Written informed consent

          -  Cardiac index before cardiopulmonary bypass &lt;2L/min/m²

        Exclusion Criteria:

          -  Missing consent

          -  Serum creatinine &gt;1.5mg/dL [&gt;123µmol/L]
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Lehmann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Klinikum der Stadt Ludwigshafen, Departement of Anesthesiology and Intensive Care Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Klinikum der Stadt Ludwigshafen, Department of Anesthesiology and Intensive Care Medicine</name>
      <address>
        <city>Ludwigshafen</city>
        <zip>67063</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Hausmann H, Potapov EV, Koster A, Krabatsch T, Stein J, Yeter R, Kukucka M, Sodian R, Kuppe H, Hetzer R. Prognosis after the implantation of an intra-aortic balloon pump in cardiac surgery calculated with a new score. Circulation. 2002 Sep 24;106(12 Suppl 1):I203-6.</citation>
    <PMID>12354734</PMID>
  </reference>
  <reference>
    <citation>Lehmann A, Boldt J. New pharmacologic approaches for the perioperative treatment of ischemic cardiogenic shock. J Cardiothorac Vasc Anesth. 2005 Feb;19(1):97-108. Review.</citation>
    <PMID>15747280</PMID>
  </reference>
  <reference>
    <citation>Böhrer H, Schmidt H, Motsch J, Gust R, Bach A, Martin E. Gastric intramucosal pH: a predictor of survival in cardiac surgery patients with low cardiac output? J Cardiothorac Vasc Anesth. 1997 Apr;11(2):184-6.</citation>
    <PMID>9105990</PMID>
  </reference>
  <reference>
    <citation>Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, Buller CE, Jacobs AK, Slater JN, Col J, McKinlay SM, LeJemtel TH. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999 Aug 26;341(9):625-34.</citation>
    <PMID>10460813</PMID>
  </reference>
  <reference>
    <citation>Adams HA, Baumann G, Gänsslen A, Janssens U, Knoefel W, Koch T, Marx G, Müller-Werdan U, Pape HC, Prange W, Roesner D, Standl T, Teske W, Werner G, Zander R; I.A.G.-Schock. [Definition of shock types]. Anasthesiol Intensivmed Notfallmed Schmerzther. 2001 Nov;36 Suppl 2:S140-3. German.</citation>
    <PMID>11753724</PMID>
  </reference>
  <reference>
    <citation>Cerrahoglu M, Iskesen I, Tekin C, Onur E, Yildirim F, Sirin BH. N-terminal ProBNP levels can predict cardiac failure after cardiac surgery. Circ J. 2007 Jan;71(1):79-83.</citation>
    <PMID>17186982</PMID>
  </reference>
  <reference>
    <citation>Provenchère S, Berroeta C, Reynaud C, Baron G, Poirier I, Desmonts JM, Iung B, Dehoux M, Philip I, Bénessiano J. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med. 2006 Apr;34(4):995-1000.</citation>
    <PMID>16484891</PMID>
  </reference>
  <reference>
    <citation>Pölönen P, Ruokonen E, Hippeläinen M, Pöyhönen M, Takala J. A prospective, randomized study of goal-oriented hemodynamic therapy in cardiac surgical patients. Anesth Analg. 2000 May;90(5):1052-9.</citation>
    <PMID>10781452</PMID>
  </reference>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 21, 2007</study_first_submitted>
  <study_first_submitted_qc>January 3, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 4, 2008</study_first_posted>
  <last_update_submitted>November 23, 2009</last_update_submitted>
  <last_update_submitted_qc>November 23, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 25, 2009</last_update_posted>
  <responsible_party>
    <name_title>Dr Andreas Lehmann</name_title>
    <organization>Klinikum der Stadt Ludwigshafen, Department of Anaesthesiology and Intensive Care Medicine</organization>
  </responsible_party>
  <keyword>cardiac surgery</keyword>
  <keyword>low cardiac output</keyword>
  <keyword>natriuretic peptide B</keyword>
  <keyword>mortality</keyword>
  <keyword>morbidity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiac Output, Low</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

